Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma

As the first oral multi-target anti-tumor drug proved for the treatment of patients with advanced liver cancer in 2007, sorafenib has changed the landscape of advanced hepatocellular carcinoma (HCC) treatment. However, drug resistance largely hinders its clinical application. Non-coding RNAs (ncRNAs...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Yongting Lai, Bing Feng, Mubalake Abudoureyimu, Yingru Zhi, Hao Zhou, Ting Wang, Xiaoyuan Chu, Ping Chen, Rui Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-11-01
Subjects:	hepatocellular carcinoma (HCC) sorafenib resistance non-coding RNAs (ncRNAs) microRNAs (miRNAs) long non-coding RNAs (lncRNAs)
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2019.01156/full